PubMed:32174267 / 783-855
Annnotations
LitCovid-PAS-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
EnjuParser_T123 | 0-2 | PRP | denotes | We |
EnjuParser_T124 | 3-10 | RB | denotes | further |
EnjuParser_T125 | 11-19 | VBD | denotes | compared |
EnjuParser_T126 | 20-24 | NNS | denotes | pros |
EnjuParser_T127 | 25-28 | CC | denotes | and |
EnjuParser_T128 | 29-33 | NNS | denotes | cons |
EnjuParser_T129 | 34-36 | IN | denotes | of |
EnjuParser_T130 | 37-43 | JJ | denotes | common |
EnjuParser_T131 | 44-53 | JJ | denotes | molecular |
EnjuParser_T132 | 54-65 | NNS | denotes | diagnostics |
EnjuParser_T133 | 66-68 | IN | denotes | in |
EnjuParser_T134 | 69-71 | NN | denotes | UP |
EnjuParser_R124 | EnjuParser_T125 | EnjuParser_T124 | arg1Of | compared,further |
EnjuParser_R125 | EnjuParser_T123 | EnjuParser_T125 | arg1Of | We,compared |
EnjuParser_R126 | EnjuParser_T127 | EnjuParser_T125 | arg2Of | and,compared |
EnjuParser_R127 | EnjuParser_T126 | EnjuParser_T127 | arg1Of | pros,and |
EnjuParser_R128 | EnjuParser_T128 | EnjuParser_T127 | arg2Of | cons,and |
EnjuParser_R129 | EnjuParser_T127 | EnjuParser_T129 | arg1Of | and,of |
EnjuParser_R130 | EnjuParser_T132 | EnjuParser_T129 | arg2Of | diagnostics,of |
EnjuParser_R131 | EnjuParser_T132 | EnjuParser_T130 | arg1Of | diagnostics,common |
EnjuParser_R132 | EnjuParser_T132 | EnjuParser_T131 | arg1Of | diagnostics,molecular |
EnjuParser_R133 | EnjuParser_T125 | EnjuParser_T133 | arg1Of | compared,in |
EnjuParser_R134 | EnjuParser_T134 | EnjuParser_T133 | arg2Of | UP,in |
LitCovid-ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-72 | DRI_Outcome | denotes | We further compared pros and cons of common molecular diagnostics in UP. |
LitCovid-OGER
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 20-24 | PR:000023601;PR:Q08761;PR:000013269;PR:P53813 | denotes | pros |
LitCovid-sentences-v1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T7 | 0-72 | Sentence | denotes | We further compared pros and cons of common molecular diagnostics in UP. |
LitCovid-TimeML
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
tok133 | 0-2 | PRP | denotes | We |
tok134 | 3-10 | JJ | denotes | further |
tok135 | 11-19 | VBN | denotes | compared |
tok136 | 20-24 | NNS | denotes | pros |
tok137 | 25-28 | CC | denotes | and |
tok138 | 29-33 | NNS | denotes | cons |
tok139 | 34-36 | IN | denotes | of |
tok140 | 37-43 | JJ | denotes | common |
tok141 | 44-53 | JJ | denotes | molecular |
tok142 | 54-65 | NNS | denotes | diagnostics |
tok143 | 66-68 | IN | denotes | in |
tok144 | 69-71 | IN | denotes | UP |
tok145 | 71-72 | . | denotes | . |
lookup26 | 0-2 | stop | denotes | We |
lookup27 | 66-68 | country_code | denotes | in |